Ivan Mestrangelo

Ivan Mestrangelo serves as the Chairman of the Board at MediCrops® AG, providing strategic leadership and ensuring the Board's effectiveness in defining and implementing the company's direction and strategy. In addition to this role, Ivan is the Chief Executive Officer at MediCrops® Holding AG, an international pharmaceutical company based in Switzerland that specializes in prescription THC-containing cannabis products, and focuses on improving the well-being of millions globally. Ivan also holds the position of Chairman at TopPharm and Topmed AG and serves as Director at Swiss Alpinopharma and AVEXIA HEALTH AG. With extensive entrepreneurial experience in the food, health, and pharmaceutical sectors, Ivan has a proven track record in scaling businesses from initial vision to successful operational phases. Ivan Mestrangelo is a Certified International Investment Analyst, having completed training at AZEK, The Swiss Training Centre for Investment Professionals.